Published in Lab Business Week, September 5th, 2004
With the inaction of Purdue with respect to this option, the exclusivity granted to Purdue has terminated and Elite intends to recommence negotiations to license its proprietary abuse-resistance technology to other companies.
Bernard Berk, Elite's CEO and president, said, "Elite placed other interested parties on hold during Purdue's exclusive negotiation period and we are excited to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.